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Cell fate decisions during development are governed by multi-factorial regulatory
mechanisms including chromatin remodeling, DNA methylation, binding of transcription
factors to specific loci, RNA transcription and protein synthesis. However, the
mechanisms by which such regulatory “dimensions” coordinate cell fate decisions
are currently poorly understood. Here we quantified the multi-dimensional molecular
changes that occur in mouse embryonic stem cells (mESCs) upon depletion of Estrogen
related receptor beta (Esrrb), a key pluripotency regulator. Comparative analyses of
expression changes subsequent to depletion of Esrrb or Nanog, indicated that a
system of interlocked feed-forward loops involving both factors, plays a central part in
regulating the timing of mESC fate decisions. Taken together, our meta-analyses support
a hierarchical model in which pluripotency is maintained by an Oct4-Sox2 regulatory
module, while the timing of differentiation is regulated by a Nanog-Esrrb module.
Keywords: stem cells, epigenetics, multi-omics network, feed forward regulatory loops, proteomics
INTRODUCTION
Understanding how embryonic and induced pluripotent stem cells (ESCs and iPSCs, respectively)
regulate cell fate decisions is crucial to realizing their biomedical potential (Liu et al., 2020). The
pluripotent state is maintained by intrinsic and extrinsic signals that converge on a network of core
transcription factors (TFs) including Oct4, Sox2, and Nanog among others (Boiani and Schöler,
2005; Ivanova et al., 2006; Wang et al., 2006; Chen et al., 2008; Papatsenko et al., 2015; Verneri
et al., 2020). These factors are interconnected via transcriptional and protein-protein interactions
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(Wang et al., 2006; Pardo et al., 2010; van den Berg
et al., 2010). However, the exact order of these interactions
and the overall molecular mechanisms of the pluripotency
network remain unclear.
The diverse phenotypic outputs of the core transcriptional
puripotency and self-renewal network are directly or indirectly
determined by genetic programs regulated via TF binding to the
promoter regions of pluripotency regulators and differentiation
inducers and this is mediated through changes in epigenetic states
of DNA and chromatin at specific loci. From this point of view,
network regulatory functions have clear multidimensionality.
While previously many studies were focused on one or two
dimensions (e.g., mRNA expression and/or TF binding) at a
single time-point, now more studies are starting to address
the dynamics of multidimensionality of regulatory networks as
they process biological information during cell fate transitions
(Lu et al., 2009; Verneri et al., 2020). The goal of the current
study is to elucidate global dynamic changes across multiple
regulatory dimensions promoted by the depletion of Estrogen
related receptor beta (Esrrb), a major core pluripotency TF.
The orphan nuclear receptor Esrrb first emerged as a core
pluripotency TF when it was shown that depletion by shRNA
results in loss of pluripotency accompanied by differentiation
toward epiblast-derived lineages, such as mesoderm and
neuroectoderm (Ivanova et al., 2006; Festuccia et al., 2018).
Further evidence came from observations that Esrrb can
substitute cMyc and Klf4 in iPSC reprogramming (Feng et al.,
2009). Interactions of Esrrb with Oct4 and Nanog were
demonstrated using genetics and biochemistry. Specifically, Esrrb
and Oct4 co-occupy the Nanog proximal promoter and positively
regulate its expression (van den Berg et al., 2008). Recent results
demonstrating co-binding of Esrrb and Sox2 support this view
and suggest that Esrrb is among the key TFs present in ESC
while absent in more mature epiblast-derived stem cells (EpiSC)
(Hutchins et al., 2013).
Additional studies have shown that the ability of Nanog
to confer LIF-independent self-renewal depends on Esrrb and
over expression of Esrrb can maintain self-renewal even without
Nanog. In addition, Esrrb over expression can recapitulate Nanog
activity during iPSC reprogramming (Festuccia et al., 2012). It
has also been demonstrated that Esrrb is necessary and sufficient
to mediate self-renewal downstream of the Wnt/Gsk3/Tcf3
signaling pathway (Martello et al., 2012). Tcf3 is a transcriptional
repressor of pluripotency and is inactivated by Gsk3 in the
presence of Wnt signals. Global analyses of Tcf3 target genes
pointed to Esrrb as the most likely target TF mediating repression
by Tcf3 (Martello et al., 2012). Together, these findings suggest
a high position for Esrrb in the hierarchy of pluripotency
TFs. Moreover, there appears to be at least partial functional
redundancy between Esrrb and Nanog mediated by a highly
interconnected regulatory module in which Esrrb and Nanog are
linked by protein–protein as well as transcriptional interactions
(Loh et al., 2006; Wang et al., 2006; van den Berg et al., 2008, 2010;
Zhang et al., 2008).
Global molecular changes following shRNA-mediated
depletion of Nanog were previously described by our group
(Lu et al., 2009). Here, we expand these analyses for Esrrb
depletion by considering five regulatory dimensions: (i)
dynamics of global mRNA, (ii) dynamics of promoter
methylation, (iii) dynamics of the nuclear proteome, and
dynamics of (iv) activating (H3K4me3) as well as (v) repressive
(H3K27me3) histone marks and provide a comprehensive
view of evolving cell fate changes during the exit of the
pluripotent state.
Meta analyses of the five regulatory dimensions and
superposition of the current Esrrb and previous Nanog datasets
(Ivanova et al., 2006; Loh et al., 2006; Lu et al., 2009; Macarthur
et al., 2012), reveal several topological elements including
network motifs linking Esrrb and Nanog with other core
pluripotency TFs and their targets. Commonly identified network
motifs such as feed-forward (FFL) or bi-parallel loops (BPLs)
involve both TF/target interactions. In general, FFL are known to
be widely present in biological networks (Milo et al., 2002). Along
with the structural analysis of the pluripotency gene regulatory
network architecture (PGRN), we have found a hierarchical
model in which pluripotency is maintained by an Oct4-Sox2




The murine ESC lines with controllable Esrrb expression
(Esrrb_R) or controllable Nanog expression (Nanog_R) were
constructed and characterized previously (Ivanova et al., 2006),
and were maintained as described on irradiated primary mouse
embryonic fibroblasts (MEFs). For all experiments, ESCs were
cultured on 0.1% gelatin-coated tissue culture plates without
feeder cells. To induce differentiation, we withdrew Doxycycline
(Dox) (1 µg ml-1, Sigma) from the media while maintaining all
other routine ESC nutrients: D-MEM–High Glucose (Dulbecco’s
modified Eagle’s medium-1X-High Glucose) (Gibco, Invitrogen),
15% FBS (fetal bovine serum) (Hyclone, Thermo Fisher
Scientific), 100 mM MEM non-essential amino acids, 0.1 mM
2-mercaptoethanol, 1 mM L-glutamine, Penicillin/Streptomycin
(Gibco, Invitrogen) and 103 U ml−1 LIF (Chemicon, Millipore).
All cell cultures were maintained at 37◦C with 5% CO2
and cells were plated at a density of 3 × 105 cells per
10 cm dish.
Microarray Gene Expression Profiling
RNA probes from each time point were hybridized to Affymetrix
Gene Chip Mouse Gene 1.0 ST microarrays (three biological
replicates: 12 arrays in total) according to the manufacturer’s
protocols by the Genomics Core Laboratory in The Institute for
Personalized Medicine at Mount Sinai Medical Center. Data were
normalized using the Robust Multichip Average (RMA) method
in the Affymetrix Expression Console software. Expression
measurements were obtained by taking the mean readings for
gene-specific probe sets and the data were log2 normalized.
Microarray data analysis is described at the Supplemental
Experimental Procedures file.
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Array-Based Methylation Analysis Using
HELP
The HELP assay was performed as previously described
(Khulan et al., 2006). We used the HELP mouse promoter
array MM9_HX3 on a 720K platform which is designed to
cover 117,000 HpaII amplifiable fragments (genomic sequences
between two flanking HpaII sites 200–2000 bp apart) within
CpG islands and promoters of the well characterized RefSeq
genes derived from the UCSC RefFlat files. Hybridization was
performed at the Weill Cornell Medical College Epigenomics
Core Facility. Scanning was performed using a NimbleGen
MS 200 scanner. For array-based methylation data analyses
see Supplementary Table 4, which contains the genes that
significantly changed their methylation state in the Esrrb and
Nanog time series.
Chromatin Immunoprecipitation
Chromatin immunoprecipitations (ChIPs) were performed
as described (Boyer et al., 2005). Images acquired from
the Solexa sequencer were processed through the bundled
Solexa image extraction pipeline and aligned to the Mouse
July 2007 assembly (NCBI37/mm9) using ELAND software.
Supplementary Figure 1E shows the specificity of the anti-Esrrb
antibody used for ChIP and Supplementary Figure 1F show the
enrichment of the Esrrb tags relative to the TSS.
ITRAQ
Nuclear protein samples were prepared using a previously
described method (Hsu and Hung, 2007; Supplementary
Figure 1G). Proteomic measurements were performed as follows.
Samples from the four time points (day 0, and days 1, 3,
and 5 after Dox removal) were labeled using eight channel
isobaric tagging reagents [isobaric tag for relative and absolute
quantification (iTRAQ), Applied Biosystems] according to the
published protocol (Unwin et al., 2010). Data analyses were
performed using ProteinPilot v3 software (AB Sciex). Only
proteins detected with a minimum of two or more high-
scoring spectra (likelihood p-value < 0.005) were accepted. The
combined search results led to a set of 1790 high-confidence
protein identifications (Supplementary Figures 1H,I).
RESULTS
Meta-Analysis of Global Molecular
Changes Resulting From Esrrb Removal
In order to explore the function of Esrrb and the Nanog/Esrrb
module we analyzed genome wide epigenetic, transcriptional and
post-transcriptional processes regulated by Esrrb. For this study,
we utilized a lentiviral/shRNA-based genetic complementation
system to deplete Esrrb under serum/Lif conditions (Ivanova
et al., 2006; Lee et al., 2012; Figure 1A and see Supplementary
Figures 1A–D for controls of the differentiation process). We
measured temporal changes for five regulatory layers (Figure 1B)
including: (1) mRNA levels (microarrays), (2) promoter DNA
methylation patterns (HpaII tiny fragment Enrichment by
Ligation-mediated PCR, HELP-assay) (Khulan et al., 2006),
(3) nuclear proteins (isobaric tag mass spectrometry, iTRAQ)
(Unwin et al., 2010), (4) genome-wide H3K4me3 (chromatin
immunoprecipitation coupled with DNA sequencing, ChIP-seq),
and (5) genome wide H3K27me3 ChIP-seq modification levels.
We also identified (6) direct Esrrb target genes (ChIP-seq)
(Supplementary Figures 1E,F). Analyses 1–5 were performed
at days 0, 1, 3, and 5 after depletion of Esrrb while analysis
6 was only performed at day 0. To obtain an integrated,
multi-dimensional view of global regulatory changes triggered
by the loss of Esrrb we have constructed a co-expression
multi-omics network based on changes observed relative to
day 0 for each regulatory layer: transcriptome, proteome,
methylome, H3K4me3, and H3K27me3 (details in Supplemental
Experimental Procedures and Supplementary Table 1). Results
of the integrative analysis through a co-expression distance
matrix across all five regulatory layers during the 5 day time
course (Figure 1B) are shown in the Figure 2 using Cytoscape
tools (Otasek et al., 2019), whereas visualization of the dynamic
changes in the network for each regulatory layer are shown in
Supplementary Movie 1 and Supplementary Figure 2 using the
GATE software (Macarthur et al., 2009).
Interestingly, using Cytoscape tools (Otasek et al., 2019)
we reiterate obtained a co-expression multi-omics network
structure across the different regulatory layers with a cut-off of
p < 10−6, which contained two major clusters; one in where
we found high representation of pluripotency genes (cluster A)
and another highly represented by differentiated genes (cluster
B) according to the Stem Cell Atlas from Pluripotency Evidence
(ESCAPE database) (Xu et al., 2013). Analyses of the cluster
A (Figure 2A) and its highly interconnected core (Figure 2D)
revealed significant downregulation of the essential components
of the core pluripotency network (Figure 2L). The core network
contains the major pluripotency factors Oct4 and Sox2 closely
linked to the other established pluripotency factors such as
Krr1 (You et al., 2015), Dppa2 and Dppa4 (Hernandez et al.,
2018), and Zscan10 (Yu et al., 2009), a known transcriptional
regulator of Oct4.
Most genes within the identified Oct4-Sox2 network module,
remarkably displayed similar dynamics across all molecular layers
(Figures 2H–K) showing tight coordination of pluripotency
genes across different epigenetic dimensions (or regulatory
layers) in the Oct4-Sox2 network domain. This strong dynamic
correlation suggests a possible mechanism of how cells maintain
the pluripotency state via direct activation.
Analysis of the methylation patterns across the clusters
notably showed a greater number of genes associated with
dynamic changes toward a hypermethylated state in cluster
A represented by pluripotency genes than in the cluster B
represented by differentiation genes (Supplementary Figure 2
global promoter methylation layer over time and Supplementary
Movie 1). In contrast, higher numbers of genes in cluster B
were associated with a downregulation in H3K27me3 levels
(Figure 2C and Supplementary Figure 2 H3K27me3 layer and
Supplementary Movie 1). A clear example of this pattern was
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Sevilla et al. Esrrb-Nanog Cell Fate Regulatory Module
FIGURE 1 | Experimental strategy and data integration. (A) Schematic representation of transgenic construct used to deplete Esrrb in order to promote
differentiation of mESCs. Lentiviral vector for conditional expression of Esrrb is shown on the top (Ivanova et al., 2006). Endogenous Esrrb is depleted with short
hairpin (sh) RNA and complemented by shRNA “immune” version of Esrrb expressed in a doxycycline (Dox)-dependent manner. Removal of Dox results in
downregulation of the exogenous Esrrb leading to differentiation. FLAP is a nucleotide segment that improves transduction efficiency; hH1P-Esrrb is the endogenous
Esrrb specific shRNA cassette (in blue); pTRE-Esrrb is GFP-tagged exogenous Esrrb cassette (in green); WRE is the woodchuck hepatitis virus post-transcriptional
regulatory element. (B) Experimental time course, analyzed data types and data integration strategy. At the initial day 0 time point, Esrrb is expressed in the presence
of Dox; at day 1, 3, and 5 time points Esrrb is downregulated following removal of Dox. Each data type (epigenetic, transcriptional, mRNA, and proteomic) is
collected at each time point and integrated into a single multi-dimensional time-series data set. (See also Supplementary Figure 1 for time series controls.)
found within the core network, extracted from the pluripotency
cluster based on the known pluripotency markers (Figure 2D).
In this network, genes linked to the Oct4-Sox2 domain (Pou5f1,
Dppa4, Rnf125, Zscan10, and Krr1) were also associated with
changes in promoter methylation increasing its methylated
state, but not with changes in H3K27me3 levels (Figure 2J
and Supplementary Figure 3A). This suggests that promoter
methylation could participate in the immediate response for
shutting-down pluripotency genes as the majority of the gene
promoter’s, transit from a hypomethylated state toward a
hypermethylated state by day 5, especially in the cluster A where
we observed more genes related to pluripotency (Supplementary
Figure 2). A separate analysis of the global methylome using
profile clustering also corroborate that the majority of the gene’s
promoters (even higher fraction than in the case of Nanog
depletion) undergo transition towards a hypermethylated state
by day 5 (Supplementary Figure 3B). Pairwise analysis of
mRNA and protein level dynamics has shown high coherence
of mRNA and protein expression levels for most pluripotency
genes (Supplementary Figure 4A and Supplementary Movie 2).
A majority of Esrrb target genes were found to be associated with
cluster A, as well (Figures 2B,D and Supplementary Table 2).
Gene Ontology (GO) analyses of the two clusters using the gene
set enrichment web server, Enrichr (Kuleshov et al., 2016) showed
enrichment for cytoskeleton, actin binding and cell adhesion
categories in cluster B, the one related with differentiation.
Enrichment of Wnt signaling components was also evident
in cluster B, suggesting that depletion of Esrrb promotes the
activation of this pathway (Figures 2E–G).
Synergistic and Unique Functions of
Esrrb and Nanog in Pluripotency and
Differentiation
To characterize the specific roles of Esrrb and Nanog in
the pluripotency network we constructed a co-expression
gene network (Otasek et al., 2019) based on our Esrrb and
previously published Nanog time-series depletion data for
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Sevilla et al. Esrrb-Nanog Cell Fate Regulatory Module
FIGURE 2 | Meta-analysis of differentiation reveals Oct4-Sox2 activation domain. (A) Co-expression network constructed from time-series data encompassing 1563
genes/gene-products and five types of dynamic measurements (levels of mRNA, protein, promoter DNA methylation, H3K4me3, and H3K27me3). Each node
represents a gene/gene product, and the edges connect those gene/gene products whose expressions are similar across the five regulatory layers analyzed. The
network shows the presence of two global clusters, cluster A represented by pluripotency genes (P = 4.6E-0.3) and cluster B represented by differentiating genes
(P = 2.6E-0.1) according to the ESCAPE database (Xu et al., 2013). Green dots represent well-known pluripotency gene/gene products and blue dots represent
differentiated gene/gene products, respectively as examples. (B) Distribution of Esrrb target genes in the network shows that the majority are localized in cluster A.
(Continued)
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FIGURE 2 | Continued
(C) Genes with changing promoter DNA methylation levels (green nodes) are highly represented in cluster A (Supplementary Figure 2 shows their change toward a
hypermethylated state by day 5). In contrast, genes with changing H3K27me3 levels (blue nodes) are preferentially localized cluster B (Supplementary Figure 2
shows the erase of this mark by day 5). (D) The largest interconnected subnetwork, containing pluripotency genes and their direct neighbors (see location of Pou5f1
cluster A in panel A). Pluripotency “seed” genes are represented by large circles, direct Esrrb targets are in red and a hit from a high-content shRNA screen is in blue.
Oct4 occupies the central position in the network with the majority of Esrrb target genes as close neighbors. (E–G) Distribution of selected GO terms in cluster A and
cluster B. Only GO terms significantly enriched in each of the two clusters were considered using the gene set enrichment web server Enrichr (Kuleshov et al., 2016).
Genes present in cluster B show enrichment in cytoskeleton, actin binding, cell adhesion, and Wnt signaling categories. (H–K) Dynamic expression profiles for
gene/gene-products included in the network (D). Four types of data (mRNA, protein, promoter DNA methylation, and H3K4me3) are shown. Dynamic changes
within each regulatory layer are in good agreement among all genes. (L) Validation of predicted expression levels for Rnf125, Zscan10, Dppa2, Krr1; gene expression
changes were measured by qRT-PCR. All data are represented as mean ± SD; n = 3 and p < 0.05 (one-way ANOVA and Bonferroni’s post-test). ∗∗P < 0.01,
∗∗∗P < 0.001.
transcriptome (Lu et al., 2009) and identified gene clusters, with
characteristic expression and TF binding properties (Figure 3A,
Supplementary Movie 3, and Supplementary Table 3). Given
that many genes in the integrated Esrrb-Nanog data set (1615
significantly changing genes) were targets of more than one TF,
we included in the analyses the in vivo binding patterns of the
four master pluripotency regulators (Oct4, Sox2, Nanog, and
Esrrb) (Chen et al., 2008; Kim et al., 2008; Marson et al., 2008).
The co-expression network based on the Nanog and Esrrb
gene expression changes revealed eight major clusters. Based
on the distribution of pluripotency markers (Figure 3A, genes
marked in red across the different clusters), cluster 1 contained
mostly pluripotency genes based on the ESCAPE database (Xu
et al., 2013). Genes in this cluster were strongly downregulated
in response to depletion of either Esrrb or Nanog. Analysis of
TF binding has shown that most genes in cluster 1 are targets of
all four major pluripotency TFs (Esrrb, Nanog, Oct4, and Sox2,
see the box “cluster 1” in the Figure 3A). In contrast, cluster
3 represents differentiation-specific genes upregulated by day 5;
genes in clusters 1 and 3 respond to both Esrrb and Nanog
depletion in a coherent manner. However, it is interesting to note
that the average TF binding pattern in cluster 3 is largely opposite
to that in the pluripotency cluster 1. Targets of Esrrb, Oct4 and
Sox2 are underrepresented in cluster 3 (see box labeled cluster
3), while targets of Nanog are slightly overrepresented. This
suggests that Nanog has a major repressive function when bound
to many differentiation genes. This fact was also revealed when
we performed the analysis of promoter methylation for both
Nanog an Esrrb knockdown time-series. In the case of Nanog
removal, we observed more genes losing promoter methylation
marks (hypomethylation) than in the case of Esrrb removal
(Supplementary Figure 3B and Supplementary Table 4). Cluster
2 is the most interesting because it contains genes that are
conversely expressed after depletion of Nanog or Esrrb; thereby
illustrating specific functions for the two pluripotency regulators.
According to the averaged expression profiles, many genes in
this group are activated by Esrrb and repressed by Nanog (but
not vice versa). The TF binding profiles in cluster 2 show
moderate over representation of all pluripotency TFs, with the
exception of Oct4.
Interestingly, the Fgf signaling pathway receptor Fgfr2, was
identified among the genes that are conversely expressed after
depletion of Esrrb or Nanog (cluster 2). Genomic regions at Fgfr2
promoter contain binding sites for all four TFs considered in this
study (Esrrb, Nanog, Oct4, and Sox2).
Further inspection of the co-expression map revealed that
genes in cluster 4 are downregulated only in the absence of
Esrrb but are mainly regulated by Oct4 strengthening a close
interaction between Esrrb and Oct4 in the regulation of this
subset of genes. Cluster 5 contains genes upregulated in the
absence of Esrrb, which are mostly regulated by Oct4, Sox2, and
Nanog but not by Esrrb. In contrast, cluster 6 represents genes
upregulated upon removal of Esrrb that are targeted largely by
Esrrb itself. This shows that Esrrb not only plays a role as a major
pluripotency factor but also has important functions during late
differentiation. Finally, clusters 7 and 8 contain genes selectively
responding to Nanog, but not Esrrb depletion; genes outside the
eight co-expression clusters show no responses to depletion of
Esrrb or Nanog and no significant binding by the pluripotency
TFs (data not shown). Figure 3B shows experimental RT-qPCR
validation of some pluripotency genes as well as some genes that
respond to depletion of Esrrb or Nanog.
Predicted Properties of Network Motifs
Linking Esrrb and Nanog With Their
Targets
Since we observed that, many genes coherently respond to
both Esrrb and Nanog upon an external stimulus (Doxycycline
removal), we focused our analysis on exploring potential FFL
motif types linking these two regulators, as these kind of motifs
need a respond to external stimuli. FFL motifs commonly occur
in biological networks and play important functions in many
regulatory pathways (Shen-Orr et al., 2002; Mangan and Alon,
2003; Goentoro et al., 2009; Papatsenko and Levine, 2011). Each
FFL has a unidirectional structure consisting of three nodes: an
upstream regulator X that regulates a downstream regulator Y,
which in turn regulates a downstream target Z. An additional
edge is directed from X to Z, thus closing a unidirectional
“loop” (Figure 4B). Each interaction can be suppressing or
activating, resulting in eight distinct FFL structures (Mangan and
Alon, 2003). Here we have considered FFLs incorporating Esrrb
(X), Nanog (Y), and their potential target genes (Z). Analysis
of transcriptional changes classified in fast, middle, and slow
responses upon depletion of Esrrb or Nanog showed 2 different
structural types of FFL motifs, the coherent type I FFL (C1-
FFL) and the coherent type 3 FFL(C3-FFL) from the possible
eight types when either Esrrb or Nanog is knockdown (Mangan
and Alon, 2003; Figure 4A). Interestingly, coherent FFLs of
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Sevilla et al. Esrrb-Nanog Cell Fate Regulatory Module
FIGURE 3 | Co-expression map for gene responses to depletion of Nanog or Esrrb. (A) Co-expression network based on time-series data collected after Nanog or
Esrrb downregulation. Nodes in the network are color-coded according to the identified co-expression clusters; large nodes in red mark pluripotency genes, while
large nodes in dark blue mark differentiation genes according to the ESCAPE database (Xu et al., 2013) (gene names from each specific cluster are shown in
Supplementary Table 3). Boxes next to each co-expression cluster show as line plots, the normalized (z-score) average expression profiles across all genes within
the cluster over the time series. Histograms in the bottom of the boxes, show the z-score average TF binding profiles for the clustered genes. The histogram
compares the fraction of known ChIP targets for a given TF in a cluster versus that expected based on entire genome. (x2 = 0 when the observed and expected
values are equal) (T-value higher than 1 means the difference is significative.) Three disconnected network domains correspond to genes with changing expression in
both Nanog and Esrrb datasets (clusters 1–3), genes with changing expression only in the Esrrb dataset (clusters 4–6) and genes with changing expression only in
the Nanog dataset (clusters 7 and 8). (B) Experimental validation of gene responses predicted from panel (A). Expression levels of Oct4, Sox2, Fgfr2, and Gli2
measured by qRT-PCR. All data are represented as mean ± SD; n = 3 and p < 0.05 (one-way ANOVA and Bonferroni’s post-test). ∗P < 0.05, ∗∗P < 0.01 and
∗∗∗P < 0.001.
types 1 (C1-FFL) and 3 (C3-FFL) account for regulation of the
majority (81%) of the Esrrb-Nanog target genes (Figures 4A,B)
and all genes presented a decay or growth in expression in a
slow time scale.
One interesting property of the coherent FFLs is delay to
upstream stimuli. If expression of a downstream target gene
(Z) requires expression of both upstream regulators (X, Y) but
only one of the two responds to an input signal (Doxycycline),
the expression of the second regulator causes an expression
delay or a slow response (Mangan and Alon, 2003).This effect is
shown schematically in Figure 4B. In this context, the “signal”
(removal of Doxycycline) causes the downregulation of Esrrb
or Nanog expression respectively in each time course where
either the Esrrb-R or the Nanog-R rescue clone were used, and
dynamics of genes downstream of Esrrb and Nanog provided a
measurable “response” from which putative regulatory logic can
be inferred. Notably, as Nanog levels are not completely abolish
upon Esrrb depletion (Figure 4C), this implies a certain delay
in the downregulation of Esrrb-Nanog target genes (Figure 4A).
This delayed response, for a certain group of genes, is what we
observed in each time series experiments with either (Esrrb-
R) or (Nanog-R) cell lines, which is characteristic of coherent
FFL regulation with an “OR” logic when the input signal is off
(Mangan and Alon, 2003).
Experimental validation of the delayed or slow predicted
responses from genes of the C1-FFL1 type was carried out using
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 February 2021 | Volume 9 | Article 630067
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FIGURE 4 | Predicted time delay responses in the Esrrb-Nanog domain. (A) Hierarchical clustering of expression changes of Esrrb and Nanog targets during both
downregulation time courses. The black, gray and white map on the right show’s classification of the target gene responses as fast, medium or slow, respectively;
the fourth and fifth columns mark direct targets of Oct4 and/or Sox2, respectively. (B) Structure of the coherent type 1 (C1-FFL) and type 3 (C3-FFL) feed-forward
loops with an OR logic. Transcription factor X regulates transcription factor Y, and both regulate a target gene, Z. Sx is the inducer signal that can be ON or OFF.
Graph of the time delay response of FFL to the OFF inducer signal step (C) Gene expression levels measured by qRT-PCR of Esrrb (upper graph) and Nanog (lower
graph) following Esrrb (red graph) or Nanog (blue graph) depletion. All data are represented as mean ± SD; n = 3 and p < 0.05 (one-way ANOVA and Bonferroni’s
post-test). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. (D) Experimental validation of the delayed or “slow” predicted responses for the C1-FFL. Expression levels of,
Trim25 and Sumo3 measured by qRT-PCR following Esrrb depletion (red graph) or Nanog depletion (blue graph). All data are represented as mean ± SD; n = 3 and
p < 0.05 (one-way ANOVA and Bonferroni’s post-test). ∗P < 0.05.
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RT-PCR (Figure 4D). The delayed or slow response effect can
be observed in the downregulation of the gene Sumo3 and
Trim25 (Figure 4D) in comparison with the dynamics observed
in other genes like Gli2 (Figure 3B), not participating in this
type of motif as only Esrrb binds its promoter but not Nanog
(Supplementary Table 2).
From this analysis we conclude that time delay responses
in the Esrrb-Nanog domain may provide a temporal window
necessary for network information processing and proper
response to signals incoming via Esrrb or Nanog.
Position of the Esrrb-Nanog Module in
the Transcription Regulatory Hierarchy
of mESC
Based on the Esrrb time course data from this study, we
explored the position of the Esrrb/Nanog module within the
mESC PGRN. To account for a hierarchical model that governs
the pluripotent state we integrated data from the present study
with retrieved genomic binding data (Chen et al., 2008; Kim
et al., 2008; Marson et al., 2008; Martello et al., 2012) and
expression data after depletion of the main pluripotency TFs
Oct4 (Ivanova et al., 2006; Loh et al., 2006; Matoba et al.,
2006), Sox2 (Ivanova et al., 2006), Nanog (Ivanova et al., 2006;
Loh et al., 2006; Lu et al., 2009; Macarthur et al., 2012),
and Esrrb (Ivanova et al., 2006; Feng et al., 2009; and the
present study). A Bayesian transcriptional network has been
reconstructed based on immediate responses (1 or 2 days)
following depletion of a given TF. Such analyses identified
genes that respond quickly to concentration changes of a
potential upstream regulator and thus, are more likely to
represent direct transcriptional targets. Supplementary Table 5
shows the most probable TF targets, ranked according to
the level of significance. From these data, high confidence
targets of Esrrb are Sox2 and Nanog occupying ranks 12
and 23 among all TFs (1578 murine TFs were taken into
account). This represents the 0.8 and 1.5% top percentiles,
respectively. Even more strikingly, Esrrb occupies rank 2 among
Nanog targets as well as among targets of Sox2. Among
Oct4 targets Esrrb occupies rank 25, higher than Sox2 (rank
64) and Nanog (rank 108). These data strongly supported
the existence of mutual interactions between Esrrb/Nanog
and Esrrb/Sox2 (Figure 5A). The overall architecture of the
reconstructed network suggests that Esrrb is tightly linked
to the other core pluripotency TFs and occupies the central
position in the transcriptional hierarchy. Esrrb is also close to
Nanog and Klf4, which appears to comprise the Nanog-Esrrb
module, responsible for the processing of incoming external
signals (Figure 5B). Interestingly, properties of this structural
domain are the time-delayed responses as we have shown in
Figure 4.
Several other key pluripotency factors were not found
among the immediate targets of the major core factors
(Oct4/Sox2/Nanog/Esrrb). For example, the Tcf3 repressor,
acting upstream of Nanog and Esrrb and mediating external
signals, such as Wnt was not found, thus supporting its possible
regulation by and alternative or independent network from the
one regulated by Oct4, Nanog, Esrrb, and Sox2 (not shown
in Figure 5). A second example is cMyc a TF expressed
in ESCs (Supplementary Table 5). This oncogenic TF is a
point of intersection between the pluripotency and the cancer
transcriptional networks (Kim et al., 2010).
Inspection of the reconstructed transcriptional mESC
hierarchy revealed downstream genes Sall4 and Lin28a, which
were alternatively regulated by the core TFs. These genes are
positively regulated by Oct4 (Sall4) and Sox2 (Lin28a) but
are negatively regulated by Nanog (Sall4 and Lin28a) and
Esrrb (Lin28a). This interesting mode of regulation, along
with the previously reported feedback link between Sall4 and
Oct4 (Buganim et al., 2012; Figure 5C) suggest these TFs
(Esrrb and Nanog) as candidates that trigger state switching of
the entire PGRN through a feedback regulatory mechanism.
Interestingly, the Oct4-Sox2 domain of the reconstructed
hierarchy matched the core network reconstructed from our
multi-omics analysis (compare Figures 2D, 5D); thus, suggesting
the existence of yet another structural network domain in the
pluripotency network.
Finally, we integrated mESC single cell data expression
profiles in our hierarchical model (Figure 5E) to
compare with the whole population previously analyzed
(Figure 5A) and the results showed a high degree
of conservation. 78% of the activating or repressing
interactions were preserved.
DISCUSSION
The key events that yield cell fate decisions occur over time
as regulatory networks process biological information. In fact,
it is likely that actual changes in cell phenotype may be
emergent properties of collective network dynamics (Lu et al.,
2009; Kim et al., 2020). Network dynamics and network-
mediated information processing remain largely unexplored in
any biological system. Here, we apply an integrated multi-
level and temporal experimental/computational approach for
dynamic network analyses. We acquire and integrate epigenetic,
mRNA and protein datasets from mESCs undergoing cell fate
changes in response to a single, well-defined perturbation,
the shRNA-mediated depletion of Esrrb, a key pluripotency
TF. Our studies provide a comprehensive view of biological
information processing mechanisms as pluripotent stem cells exit
the pluripotency state.
Analysis of dynamic changes in gene product levels and
epigenetic modifications revealed two major gene clusters
suggesting two major states of the regulatory mESC gene network
in the presence of serum plus Lif conditions (Figure 2A).
Genes in the first cluster are shut down upon the exit from
pluripotency, while genes in the second cluster are activated upon
differentiation. No clusters suggesting more complex patterns of
behavior (e.g., intermediate transition states) have been detected;
however, the differentiation cluster contains certain sub clusters,
potentially reflecting the presence of alternatively differentiating
cell lineages (Figures 2E–G).
The integrated multi-omic analyses based on co-expression
among the regulatory layers suggest that different epigenetic
levels contribute unequally to exit from pluripotency and
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FIGURE 5 | Hierarchy of pluripotency gene networks. (A) A Bayesian pluripotency network constructed based on knockdown (and/or knockout) differentiation
studies in combination with in vivo TF binding analyses (Supplementary Table 5, fraction of predicted targets is shown). The red arrows show activating and the
blue arrows show repressive links between the genes. Edge thickness represents the level of experimental support based on all analyzed independent data sources
(Supplementary Table 5). Esrrb is tightly linked with other core pluripotency factors, including Nanog and Sox2. (B–D) Emerging information-processing circuits in
the context of the gene network shown in A. (B) Nanog-Esrrb module, responsible for interpretation and processing external signals, such as Gsk3/Tcf signaling,
targeting Esrrb and Nanog, or Lif signaling targeting Nanog and Klfs (Lif is not shown), Klf4 is shown on the panel A. The Nanog-Esrrb module largely contains
multiple coherent feed-forward loops. (C) Feedback control circuits, such as Oct4-Nanog-Sall4 (see the panel A) are responsible for controlling Oct4 concentration
by the downstream pluripotency genes (shown in a box); largely represented by incoherent feed-forward loops with a feedback. Oct4 regulation by Sall4 is
suggested by several recent studies (Buganim et al., 2012). (D) Pluripotency maintenance unit, Oct4 and Sox2 synergistically activate most of pluripotency genes,
this unit also consists of coherent feed-forward loops. (E) Bayesian pluripotency network based on single cell data in combination with in vivo TF binding analyses.
The red arrows show activating and the blue arrows show repressive links between the genes. Gray arrows depict absent connections with respect to the whole cell
population network from Figure 5A. Cdx1 was not analyzed in the single cell data.
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initiation of differentiation. Specifically, dynamic changes in
the promoter methylation were tightly associated with the
very core of the pluripotency cluster, suggesting this as the
major mechanism responsible for shutting-down pluripotency
genes (Figure 2C). In contrast, dynamic changes associated
with the repressive H3K27me3 histone methylation mark
were largely observed in the differentiation but not the
pluripotency cluster. Although this observation might reflect
the abundance of CpG rich domains at promoters, it is
also possible that the alternative levels of regulation are
respectively more effective in erasing epigenetic memory and
facilitating alternative cell fate commitment directions upon
exiting pluripotency.
Overall, the data suggests tight functional linkage between
Esrrb and Nanog TFs (Figure 4A), which might be essential
for processing external and internal signals. Network
reconstruction studies also support the existence of the
Esrrb-Nanog domain in the context of the pluripotency
network (Figure 5B).
Based on integrative analysis of multiple knockdown studies
and in vivo binding assays we constructed a hierarchical
model describing interactions between the major TFs upon
differentiation (Figure 5). Major features of the established
hierarchy included close linkage between the Esrrb and Nanog
and the presence of incoherent feed forward loops (iFFL),
incorporating the major core pluripotency factors and some of
their target genes. Both Nanog and Esrrb were found to be the
parts of a BPL targeting Lin28a, Nanog was a part of FFL targeting
Sall4 (Figure 5C).
Such incoherent FFLs and BPLs are known to be broadly
involved in developmental pattern formation, cell fate
specification and many other biological processes, which
require switching of gene activity states and establishing
threshold concentrations.
Another interesting feature found in our reconstructed
hierarchy network is a noticeable functional difference between
the Esrrb-Nanog and Oct4-Sox2 network domains. The former
pair is involved in both activation and repression (Figure 5B,
blue and red arrows), while the latter serves mainly as a pair
of activators (Figure 5D, red arrows). The “general” activation
functions of the Oct4-Sox2 pair seem to maintain the expression
of pluripotency genes, while the functions of Esrrb-Nanog
pair more likely contribute to information processing and
decision-making.
This presence of the Oct4-Sox2 and Esrrb-Nanog modules
is also supported by systematic knockdown studies of 100 TFs
(KD-100) in mESC where the Oct4-Sox2 module maintains
pluripotency and prevents extraembryonic fates while Nanog-
Esrrb and SallL4 coordinate different signal processes preventing
cell fate differentiation (Nishiyama et al., 2013). In particular,
Sall4 plays a clear feedback control in the pluripotency
maintenance as there is evidence that Sall4 is not only regulated
by the core factors it also provides feedback control to the system
by regulating Oct4 (Figure 5C; Yang et al., 2010).
Finally, to validate our hierarchical model at the single cell
level, we analyzed single cell gene expression profiles of mESCs
(Papatsenko et al., 2015). To our surprise, 78% of the interactions
observed in the whole cell population were maintained at the
single cell level (see Figure 5E).
Recently it has been shown that iPSC reprogramming is
a stochastic process where early expression of Esrrb, Utf1,
Lin28, and Dppa2 are good predictors for cells that will
eventually yield fully reprogrammed iPSCs, expressing high
levels of Oct4 and Sox2 (Buganim et al., 2012, 2014). To
a certain degree, the reprogramming process is opposite
(reversed) to differentiation; therefore, one may expect that
the reprogramming hierarchy would be opposite to that
in differentiation. Indeed, factors predicting successful iPSC
reprogramming occupy lower positions in our hierarchical
network, while the core factor Oct4 occupies the highest position.
Such comparison of the differentiation and the reprogramming
suggest a high degree of flexibility of the pluripotency network
and its potential for dynamic rewiring.
CONCLUSION
In summary, our results suggest flexibility in the architecture
of the pluripotency network incorporating at least two
large network domains (Esrrb-Nanog and Oct4-Sox2)
and numerous feed-forward as well as feedback regulatory
interconnections that collectively control cell fate transitions in
pluripotent stem cells.
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